Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool June 27, 2011 Arundhati Parmar	St. Jude Medical's Migraine Treatment: Good for Europe, but Not the U.S.? St. Jude won't comment on whether the company plans to do a second clinical trial or whether it is confident it will win approval from the FDA without it.
The Motley Fool July 12, 2011 Arundhati Parmar	FDA Allows Expansion of St. Jude Study to Treat Severe Depression St. Jude moves forward with treatment for depression.
The Motley Fool July 21, 2011 Arundhati Parmar	New Hypertension Treatment from St. Jude Medical? St. Jude management is keeping mum on renal denervation.
The Motley Fool October 17, 2005 Stephen D. Simpson	A Stimulating Merger St. Jude will be paying $61.25 a share in cash for Advanced Neuromodulation Systems, a robust 30% premium to Friday's closing price. This deal demonstrates that large med-tech players may still be on the prowl for avenues into fast-growing new markets.
American Family Physician February 15, 2005 Beck, Sieber & Trejo	Management of Cluster Headache Cluster headache, an excruciating, unilateral headache usually accompanied by conjunctival injection and lacrimation, can occur episodically or chronically, and can be difficult to treat.
BusinessWeek March 22, 2004 Robert Barker	St. Jude: An Insider Sign To Investors? St. Jude, the patron saint of lost causes, rarely has needed to look out for his namesake, St. Jude Medical (STJ ). Since its birth in 1976, this maker of artificial heart valves, defibrillators, catheters, and sundry other cardiac devices has led a blessed life. It's in excellent health today. So why are insiders dumping the stock?
The Motley Fool July 15, 2011 Arundhati Parmar	St. Jude Medical's Novel Heart Disease Diagnostic Tool Cleared in Europe St. Jude has an inventive new heart disease treatment.
American Family Physician October 15, 2000 Sharon Scott Morey	Practice Guidelines Guidelines on Migraine: Part 2. General Principles of Drug Therapy...
The Motley Fool October 19, 2007 Billy Fisher	Keeping Pace at St. Jude Medical device maker St. Jude Medical has a strong quarter, but investors weren't impressed.
American Family Physician December 1, 2002	What Should I Know About Migraines? What are migraines?... How can my doctor tell that my headache is a migraine?... How is migraine headache treated?... What about the headache pain I'm having right now?... What are the "triptans"?... What else can I do?... etc.
American Family Physician December 15, 2004 Morris Maizels	The Patient with Daily Headaches Although the condition is challenging, appropriate treatment of patients with chronic daily headaches (CDH) can bring about significant improvement in the patient's quality-of-life.
Managed Care May 2004 Dodick & Lipsy	Advances in Migraine Management: Implications for Managed Care Organizations In response to the expense of new migraine therapies, treatment practices aimed at controlling direct costs are now the norm.
American Family Physician September 1, 2002 Millea et al.	Tension-Type Headache Tension-type headache, formerly called tension headache or muscle contraction headache, is a common condition usually self-treated with over-the-counter analgesics. Primary headache is treated symptomatically, with the goal being relief and preventing recurrence.
The Motley Fool April 19, 2007 Billy Fisher	A Saintly Quarter Shares of St. Jude Medical rise after the company announces a big quarter.
The Motley Fool January 26, 2005 Stephen D. Simpson	St. Jude Is No Lost Cause The No. 3 cardiology company posts solid growth because of continuing implantable cardioverter defibrillator (ICD) market share gains.
BusinessWeek June 7, 2004 Gene G. Marcial	St. Jude's Bruise Should Clear Up Fast St. Jude Medical (STJ ) tumbled 2%, to $73, after it revealed that the FDA had delayed for a month the approval of its new Epic CRT-defibrillator.
The Motley Fool June 1, 2005 T.G. Wolf	A Shocking Opportunity? Advanced Neuromodulation Systems has been competing quite nicely with the big boys in the emerging neurodevice segment of the neurotech industry. Investors, take note.
American Family Physician October 15, 2005 Huntington & Yuan	Topiramate (Topamax) for Migraine Prevention Topiramate is more effective than placebo for migraine prevention. Its effectiveness appears to be similar to that of other antiepileptic drugs and beta blockers.
The Motley Fool April 23, 2011	St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask.
The Motley Fool July 18, 2008 Brian Orelli	St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down.
The Motley Fool July 19, 2006 Stephen D. Simpson	Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too.
The Motley Fool April 20, 2005 Stephen D. Simpson	St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well.
The Motley Fool January 9, 2007 Billy Fisher	St. Jude's Juiced-Up Q4 The medical-device maker shows stronger vital signs. Investors, take note.
IEEE Spectrum October 2007 Morgen E. Peck	Researchers Testing New Electric Treatment for Migraines A small DC current through the skull seems to interrupt the headaches and may even prevent them
The Motley Fool June 24, 2009 Brian Orelli	Boston Scientific Helps Itself ... and Its Rivals Boston Scientific released positive results from a clinical trial testing its heart devices, but unfortunately the data is likely to help its competitors as well.
American Family Physician December 15, 2006 Mark H. Ebell	Point-of-Care Guides Clinical Question: What is the best way to diagnose migraine in patients presenting with headache?... Evidence Summary: Headache is a common reason for primary care office visits and is a complaint in more than 1% of patient visits...
Managed Care May 2005	Microcircuit Devices Deliver Considerable Relief From Chronic Pain Recent advances in pain relief revolve around longer-lasting implantable devices. Can managed care afford not to have a pain management strategy?
The Motley Fool April 11, 2008 Brian Orelli	St. Jude's Heartfelt Acquisition Medical-device maker St. Jude purchases tiny EP MedSystems.
Nurse Practitioner September 2010 Moloney & Cranwell-Bruce	Pharmacological Management of Migraine Headaches Migraine is one of the top 20 causes of disability worldwide, occurring in 17.6% of women and 5.7% of men
American Family Physician December 1, 2002 Aukerman et al.	Management of the Acute Migraine Headache As many as 30 million Americans have migraine headaches. The impact on patients and their families can be tremendous, and treatment of migraines can present diagnostic and therapeutic challenges for family physicians.
The Motley Fool September 12, 2008 Brian Lawler	A New Wrinkle for an Old Drug Allergan's muscle relaxant Botox performs well in two studies testing its ability to prevent migraine headaches.
The Motley Fool July 20, 2005 Stephen D. Simpson	Hey, Jude! Party Hearty St. Jude's ICD (implantable cardioverter defibrillator) business is on fire and fueling strong profit growth for this medical device maker. Whether your cut-off makes St. Jude a mid-cap or a large-cap, this company is certainly growing -- and the stock's valuation reflects that.
American Family Physician November 15, 2000 Sharon Scott Morey	Practice Guidelines Guidelines on Migraine: Part 4. General Principles of Preventive Therapy
IEEE Spectrum May 2005 Samuel K. Moore	Zapping Away The Blues Cyberonics Inc. plans to introduce the first implanted device that can treat a psychiatric illness.
BusinessWeek March 7, 2005 Michael Arndt	"Pacemakers" for the Rest of You Slews of tiny devices that deliver electrical stimulation to a wide variety of organs should soon become available.
American Family Physician November 1, 2000 Sharon Scott Morey	Guidelines on Migraine: Recommendations for Individual Drugs The following is an excerpt of the section in the migraine guidelines that outlines the findings from clinical studies and the specific recommendations for individual drugs...
Health June 2007 Melanie Haiken	The Best New Pain Cures?... For Women New research shows that pain can often be prevented if women use the right treatment. Here's what you should know.
The Motley Fool January 25, 2006 Stephen D. Simpson	Is St. Jude Next to Be Wooed? Can St. Jude build upon the jump-start opportunity from Guidant's troubles, or will further market share growth prove to be increasingly hard to come by? Investors, take note.
Managed Care October 2003 Martin Sipkoff	Pain Management: Health Plans Need to Take Control Insurers have not focused much on chronic pain. They should. It presents a humanitarian and business opportunity.
American Family Physician October 1, 2000 Sharon Scott Morey	Practice Guidelines Headache Consortium Releases Guidelines for Use of CT or MRI in Migraine Work-up...
The Motley Fool July 25, 2011 Jason Moser	Rising Star Buy: St. Jude Medical It's a good time to jump in on this medical-device maker.
The Motley Fool February 8, 2006 Tim Beyers	Who's Buying Now? Sometimes, insiders are buying for all the right reasons. Who's buying now? Dominion Resources... Goodrich Petroleum... iPass... ITT Educational Services... St. Jude Medical...
American Family Physician January 1, 2006 MODI Lowder	Medications for Migraine Prophylaxis Sufficient evidence and consensus exist to recommend propranolol, timolol, amitriptyline, divalproex, sodium valproate, and topiramate as first-line agents for migraine prevention.
The Motley Fool April 25, 2011 Arundhati Parmar	St. Jude: New Aortic Replacement Valve Approved St. Jude gets good news.
BusinessWeek September 3, 2007 Brian Burnsed	Texas Instruments: Processing Away The Pain Health-care innovations are coming from an unexpected source: Texas Instruments.
The Motley Fool January 25, 2011 Jason Moser	Finding Large Caps for a Winning Portfolio A screen for six large-cap ideas, picking two to add to the watchlist.
The Motley Fool January 18, 2012 Dan Caplinger	Has St. Jude Medical Become the Perfect Stock? St. Jude took a big step toward perfection when it initiated a big dividend in early 2011.
The Motley Fool October 17, 2005 Stephen D. Simpson	A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it.
Pharmaceutical Executive December 1, 2012 Ben Comer	Top Medical Innovations for 2013 The author profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability, such as neuromodulation for cluster and migraine headache.
American Family Physician September 1, 2002	Tension Headaches What is a tension headache?... What causes tension headaches?... What can I do about my tension headaches?...